INTANGIBLE ASSETS (Details) - USD ($) |
Sep. 30, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|---|---|---|---|
| INTANGIBLE ASSETS | |||
| Total cost | $ 1,040,433 | $ 1,040,433 | $ 1,040,433 |
| Accumulated amortization | (413,904) | (335,872) | (231,829) |
| Net book value | 626,529 | 704,561 | 808,604 |
| Acquired technology - Polytherapeutics | |||
| INTANGIBLE ASSETS | |||
| Total cost | 40,433 | 40,433 | 40,433 |
| Technology license - Skinvisible | |||
| INTANGIBLE ASSETS | |||
| Total cost | $ 1,000,000 | $ 1,000,000 | $ 1,000,000 |
| X | ||||||||||
- Definition Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|